High blood pressure has long been medicine's quiet adversary — present in over a billion lives, yet often invisible until the damage is done. On World Hypertension Day, Recor Medical draws attention to the stubborn third of patients for whom pills and lifestyle changes are not enough, offering a device-based therapy that quiets the overactive nerves driving their condition. The Paradise ultrasound renal denervation system, FDA-approved since late 2023, represents not a replacement for existing care but an expansion of what medicine can offer those left behind by it. Whether it will endure as a
PR Newswire UK
· May 15, 2026
· health
· 3 min read
High
Sourcing: Characterized
Recor Medical Promotes Ultrasound Therapy for Treatment-Resistant Hypertension
Hypertension affects over 1 billion people globally and remains a leading cause of heart attack, stroke, and kidney disease when uncontrolled.
◉
Health & Medicine
8046 related articles
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 100% match
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% match
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% match
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% match
Canada faces new COVID epidemic, not third wave, as variants target di…
The Globe and Mail · 99% match
Related Coverage
Google News · Aug 19
Welsh Teen's Ovarian Cancer Diagnosis Triggers Sudden Menopause
A teenager from Caernarfon experienced sudden onset menopause following an ovarian cancer diagnosis, highlighting unexpe…
JNS.org · Aug 19 Israeli study: Focused attention may reduce inflammatory responseBar-Ilan University researchers found that deliberately focusing attention on inflamed skin areas reduced inflammatory r…
foodsafetynews.com · Aug 19 UK Salmonella outbreak sickens 207, linked to imported eggsA Salmonella outbreak across the UK has infected 207 people with one death, traced to contaminated imported eggs served …
eNCA · Aug 19 DRC Ebola outbreak spreading faster than any previous epidemic, WHO warnsWHO warns the DRC Ebola outbreak is moving faster than any previous epidemic, with over 2,300 deaths from nearly 5,000 c…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
Medical device company promotes ultrasound therapy for hypertension; no geopolitical implications detected.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Recor Medical promotes ultrasound renal denervation for treatment-resistant hypertension affecting ~1.3B people globally, targeting the one-third of patients uncontrolled by medication, signaling growth in specialized medical device markets.
Market Signal
bullish
Confidence
MED
Medical devices and diagnostics
Pharmaceutical/healthcare services
Cardiovascular treatment
Healthcare technology
Hospital and clinical services
Patients with resistant hypertension gain access to innovative minimally-invasive treatment options, potentially reducing long-term healthcare costs from cardiovascular complications (heart attacks, strokes, kidney disease) and improving quality of life, though device costs may initially be high.
Regulatory bodies (FDA, EMA) may accelerate approval pathways for innovative hypertension therapies; healthcare systems may need to evaluate reimbursement policies for device-based treatments; public health initiatives may shift toward earlier detection and specialist referral protocols for treatment-resistant cases.